OneAscent Family Office’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-35,073
Closed -$837K 260
2026
Q1
$837K Buy
35,073
+1,327
+4% +$32K 0.58% 39
2025
Q4
$817K Buy
33,746
+7,468
+28% +$181K 0.55% 42
2025
Q3
$635K Sell
26,278
-5,527
-17% -$133K 0.52% 51
2025
Q2
$764K Sell
31,805
-3,471
-10% -$82.3K 0.72% 34
2025
Q1
$838K Sell
35,276
-278
-0.8% -$6.57K 0.78% 36
2024
Q4
$833K Buy
+35,554
New +$844K 1.51% 11

Other funds holding IBD

OneAscent Family Office's IBD Position: Q2 2026 in Review

OneAscent Family Office sold out of Inspire Corporate Bond ETF (IBD) in Q2 2026, closing a stake of 35,073 shares — an estimated $837K sold.

OneAscent Family Office first reported a position in IBD in Q4 2024 and held it in 6 quarters. The position peaked at $838K in Q1 2025. 110 funds tracked by Wall St. Rank hold IBD as of Q2 2026.

  • OneAscent Family Office reported no remaining Inspire Corporate Bond ETF position as of Q2 2026 after selling out during the quarter.
  • OneAscent Family Office sold 35,073 Inspire Corporate Bond ETF shares in Q2 2026, an estimated $837K.
  • OneAscent Family Office first reported a position in Inspire Corporate Bond ETF in Q4 2024 and held it in 6 quarters.
  • OneAscent Family Office's Inspire Corporate Bond ETF position peaked at $838K in Q1 2025.
  • 110 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q2 2026.

Based on OneAscent Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.